Lucius Macitentan – Buy online

USD 35.47

Sold 1,200+
Special Offer

Offline Hong Kong pharmacy with 100% genuine product guarantee

Key Highlights

Indicated for pulmonary arterial hypertension (PAH, WHO Group 1) in adults to reduce the risk of disease progression and hospitalization.

Service Promise

Direct from JapanLicensed PharmacyPharmacist CheckedEditable in Admin

Specifications

Specification
10mg*30 tablets
Manufacturer
Lucius Pharmaceuticals
Shipping
Hong Kong

10000 in stock

Product Info

English Name
Macitentan
Generic Name
Macitentan

Specifications

Specification
10mg*30 tablets
Manufacturer
Lucius Pharmaceuticals
Shipping
Hong Kong

Full Details

Indications

Indicated for pulmonary arterial hypertension (PAH, WHO Group 1) in adults to reduce the risk of disease progression and hospitalization.

How It Works

-1 (ET-1) ETA ETB , (PAH) , , , ET-1 ETA ETB ET

Pharmacology

12.1 How It Works -1 (ET-1) ETA ETB , (PAH) , , , ET-1 ETA ETB ET

Drug Interactions

7.1 CYP3A4 CYP3A4 CYP3A4 [ (12.3)] 7.2 CYP3A4 CYP3A4 HIV CYP3A4

Adverse Reactions

• - [ Precautions(5.1)] • [ Precautions(5.2)] • [ Precautions(5.3)] • [ Precautions(5.4)] 6.1 , , 742 SERAPHIN

Package Insert

Indications

Indicated for pulmonary arterial hypertension (PAH, WHO Group 1) in adults to reduce the risk of disease progression and hospitalization.

Adverse Reactions

• - [ Precautions(5.1)] • [ Precautions(5.2)] • [ Precautions(5.3)] • [ Precautions(5.4)] 6.1 , , 742 SERAPHIN

Use in Pregnancy and Lactation

8.1 ,OPSUMIT , - , , [ Precautions] OPSUMIT ERA ,

Drug Interactions

7.1 CYP3A4 CYP3A4 CYP3A4 [ (12.3)] 7.2 CYP3A4 CYP3A4 HIV CYP3A4

Clinical Pharmacology

12 12.1 How It Works (ET)-1 ET A ET B , (PAH) , ET , , ET-1 ET A ET B ET ET , 20%

Clinical Studies

14 14.1 2 , (PAH) 742 [WHO (FC) II–IV] PAH , (n=250) 3 mg (n=250) 10 mg (n=242), OPSUMIT -5 , 7 “ PAH ” 1 ≥15%

Product Reviews (13)

Filter: All Reviews
4.8★★★★★
13 customer reviews10 verified purchases
+o***e· 3 weeks ago
★★★★
+t***3· 1 months ago
Verified Purchase
★★★★★

Description

Indications

Indicated for pulmonary arterial hypertension (PAH, WHO Group 1) in adults to reduce the risk of disease progression and hospitalization.

How It Works

-1 (ET-1) ETA ETB , (PAH) , , , ET-1 ETA ETB ET

Pharmacology

12.1 How It Works -1 (ET-1) ETA ETB , (PAH) , , , ET-1 ETA ETB ET

Drug Interactions

7.1 CYP3A4 CYP3A4 CYP3A4 [ (12.3)] 7.2 CYP3A4 CYP3A4 HIV CYP3A4

Adverse Reactions

• - [ Precautions(5.1)] • [ Precautions(5.2)] • [ Precautions(5.3)] • [ Precautions(5.4)] 6.1 , , 742 SERAPHIN